The company had posted a net profit of ₹19.97 crore in the July-September period a year ago, according to a regulatory filing by Mafatlal Industries, one of the country's oldest textile institutions
Sun Pharma's Q2FY26 profit rose to Rs 3,118 crore as India, emerging markets, and rest of world drove growth; US revenues fell 4.1% despite strong gains in innovative medicines
Its total income, however, rose 14.81% to ₹2651.53 crore in the quarter under review compared to ₹2,309.33 crore a year ago, the company said in a regulatory filing
Revenue up 2% YoY to Rs 926 crore as research services offset biologics inventory correction; company maintains FY26 guidance
The private sector lender had recorded a net profit of ₹138 crore in the same quarter a year ago
The company had posted a net profit of ₹96.06 crore in the July-September quarter a year ago, according to a regulatory filing from Blue Star Ltd
Saregama's board declared an interim dividend of ₹4.50 per share for the quarter
Its revenue increased to Rs 2,762 crore for the September quarter against Rs 2,326 crore in the year-ago period, Motherson Sumi Wiring India said in a statement
Recruitment firm TeamLease said that it added 11,000 people during the September quarter, including 315 net additions in its specialised staffing business
The healthcare arm of Procter & Gamble reports steady second-quarter growth driven by brand strength, new product launches, and supply chain gains
Fairfax-backed CSB Bank reports higher profit and strong deposit growth in Q2, with stable asset quality and improved margins
Embassy REIT leased 1.5 million sq ft of office space across 20 deals in Q2FY26, including 1 msf of new leases, 0.4 msf of renewals, and 64,000 sq ft of pre-leases in Chennai, driving occupancy to 93%
India's industrial output hit a four-month high in July, rising 4.3% year-on-year, and it rose 4.1% and 4% in August and September, respectively
The company had a consolidated net profit of Rs 66.46 crore in the quarter ended on September 30, 2024, a regulatory filing showed
Consolidated net profit rose to 275.2 million rupees ($3.13 million) for the three months ended September 30, from 245.8 million rupees a year earlier
Its consolidated income during the July-September period fell to ₹846.13 crore against ₹874.70 crore in the year-ago period
Market leader SBI alone contributed 40 per cent to the total earnings of ₹49,456 crore, as per the published numbers on stock exchanges
Q2FY26 company results: Firms including Aurobindo Pharma, Muthoot Microfin, Delhivery, Blue Star, and Eureka Industries are also to release their July-September earnings reports today
The company reported consolidated PAT of ₹3,673 crore and 22% revenue growth in Q2 FY26, led by robust SUV sales, record tractor volumes, and higher margins across segments
This compares with a profit of Rs 928 crore in Q2FY25, which was boosted by an exceptional gain from the sale of its movie ticketing and events business to Zomato